Royalty Pharma plc (MUN:RPD)
Germany
· Delayed Price · Currency is EUR 33.50
-0.56 (-1.64%)
At close: Jan 2, 2026
Royalty Pharma Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 17,473 | 14,061 | 10,948 | 11,306 | 16,312 | 15,050 | Upgrade
|
| Market Cap Growth | 30.89% | 28.43% | -3.17% | -30.69% | 8.38% | -5.23% | Upgrade
|
| Enterprise Value | 27,423 | 23,614 | 20,604 | 19,119 | 25,576 | 23,466 | Upgrade
|
| Last Close Price | 33.30 | 33.67 | 23.72 | 25.42 | 36.94 | 32.06 | Upgrade
|
| PE Ratio | 26.61 | 21.41 | 13.20 | 11.01 | 407.00 | 27.62 | Upgrade
|
| PS Ratio | 8.63 | 6.94 | 5.01 | 5.31 | 7.79 | 7.48 | Upgrade
|
| PB Ratio | 2.11 | 1.70 | 1.10 | 1.24 | 1.83 | 1.67 | Upgrade
|
| P/TBV Ratio | 3.69 | 2.97 | 1.63 | 1.92 | 3.11 | 2.97 | Upgrade
|
| P/OCF Ratio | 8.24 | 6.63 | 4.09 | 4.18 | 8.13 | 8.48 | Upgrade
|
| EV/Sales Ratio | 13.41 | 11.66 | 9.42 | 8.98 | 12.22 | 11.66 | Upgrade
|
| EV/EBITDA Ratio | 20.03 | 17.74 | - | 14.11 | 29.44 | 18.36 | Upgrade
|
| EV/EBIT Ratio | 20.07 | 17.78 | 16.51 | 14.16 | 29.62 | 18.65 | Upgrade
|
| Debt / Equity Ratio | 0.92 | 0.92 | 0.74 | 0.61 | 0.75 | 0.69 | Upgrade
|
| Debt / EBITDA Ratio | 5.74 | 5.74 | - | 4.10 | 7.66 | 4.88 | Upgrade
|
| Net Debt / Equity Ratio | 0.86 | 0.86 | 0.64 | 0.56 | 0.56 | 0.48 | Upgrade
|
| Net Debt / EBITDA Ratio | 5.33 | 5.33 | - | 3.77 | 5.79 | 3.38 | Upgrade
|
| Asset Turnover | 0.13 | 0.13 | 0.13 | 0.14 | 0.13 | 0.14 | Upgrade
|
| Quick Ratio | 2.39 | 2.39 | 1.43 | 7.78 | 2.11 | 16.77 | Upgrade
|
| Current Ratio | 2.40 | 2.40 | 1.44 | 7.90 | 2.19 | 16.81 | Upgrade
|
| Return on Equity (ROE) | 13.20% | 13.20% | 13.03% | 17.34% | 2.33% | 12.32% | Upgrade
|
| Return on Assets (ROA) | 5.15% | 5.15% | 4.67% | 5.62% | 3.36% | 5.33% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.20% | 8.20% | 7.60% | 9.20% | 5.90% | 8.20% | Upgrade
|
| Earnings Yield | 3.76% | 4.67% | 7.58% | 9.08% | 0.25% | 3.62% | Upgrade
|
| Dividend Yield | 2.31% | 2.23% | 3.42% | 2.85% | 1.93% | 1.86% | Upgrade
|
| Payout Ratio | 49.06% | 49.06% | 43.83% | 31.57% | 778.21% | 46.02% | Upgrade
|
| Buyback Yield / Dilution | 4.99% | 4.99% | 1.46% | -37.66% | -5.59% | -10.48% | Upgrade
|
| Total Shareholder Return | 7.30% | 7.22% | 4.88% | -34.81% | -3.66% | -8.62% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.